Approved by Global Regulatory
and Partner Audits
In addition to the industry-leading manufacturing technology platforms, Aton has established an international level biopharmaceutical R & D, production, and operation management team, with high-quality talent reserve and perfect team structure. The core management team has more than 15 years of senior management and industry experience in drug R & D, clinical, production, CMC, quality, and compliance from leading multinational pharmaceutical companies.
张文杰
董事长、执行董事兼首席执行官
张文杰先生在医药行业拥有逾25年的商业运营经验，在2019年三月份加入复宏汉霖之前，张文杰先生是美国安进公司中国区总经理，负责安进公司在中国的业务扩展并致力于帮助中国患者早日受益于安进公司的创新产品。在张文杰先生的领导下，安进成功的组建了完整的商业化团队，并在中国上市了公司的第一个产品瑞百安。
在此之前，张文杰先生担任安进公司日本及亚太区市场执行总监，负责包括中国、日本、澳大利亚、和其它亚太国家和地区的市场及业务发展。
Aton Biotech takes quality and integrity as the principle. All employees strive to deal honestly, ethically, and fairly with our suppliers, customers, and competitors.